Eastman Chemical (EMN) is trading higher today as investors react to a fresh Wall Street upgrade. JPMorgan moved the stock to Overweight from Neutral and raised its price target to $80 from $70, pointing to a more favorable setup tied to commodity prices and a better earnings-growth profile into 2026. (investing.com)

For a cyclical name like Eastman, sentiment can shift quickly when investors see evidence that the earnings cycle may be turning. JPMorgan’s upgrade frames the recent setup as less about near-term noise and more about the potential for 2026 earnings growth, which can support a higher valuation multiple if the macro tape cooperates. (investing.com)

The next major catalyst is Eastman’s first-quarter 2026 results, scheduled for April 30, 2026. Investors will be focused on management commentary around pricing, volumes, and cost actions—especially any signals that the commodity and demand backdrop is improving enough to translate into sustained margin expansion. (value-trades.com)